AACR Cancer Progress Report

Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment.

In the United States, 40 percent of all cancers are associated with modifiable risk factors.

Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.